Literature DB >> 12736494

Diagnostic significance and clinical applications of chimeric genes in Ewing's sarcoma.

Naoko Yoshino1, Tetsuko Kojima, Satoru Asami, Shigeyasu Motohashi, Yoshikazu Yoshida, Motoaki Chin, Hiroyuki Shichino, Yukihiro Yoshida, Norimichi Nemoto, Michio Kaneko, Hideo Mugishima, Takashi Suzuki.   

Abstract

Ewing's sarcoma (ES) is one of the most malignant bone and soft tissue tumors in childhood. Morphologically, ES belongs to the small round cell tumors (SRCT). ES, peripheral primitive neuroectodermal tumor (PNET), and Askin's tumor are classified as ES family tumors (ESFT) because they share a common chromosomal translocation. The EWS-FLI1 chimeric gene is generated by t (11; 22). Other reciprocal translocations resulting in formation of chimeric genes between EWS and ETS family genes (ERG, ETV1, E1AF, and FEV) are t (21; 22), t (7; 22), t (17; 22), and t (2; 22), respectively. Although it is generally difficult to distinguish ES from SRCT, we could easily and quickly distinguish ES from other SRCT by using reverse transcription polymerase chain reaction (RT-PCR). We looked for specific chimeric genes in 23 tumor samples, including three ES clinical samples. We detected five chimeric genes in the three ES samples. Three chimeric genes, all EWS-FLI1, were detected in one ES sample. Different chimeric genes, EWS-ERG and EWS-ETV1, were detected in the other two ES samples. Moreover, because we could not detect specific chimeric genes in samples from non-ESFT, it may be possible to use this technique to diagnose ESFT and to detect tumor cell contamination before hematopoietic stem cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12736494     DOI: 10.1248/bpb.26.585

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  4 in total

1.  Askin Rosai Tumour.

Authors:  D Gulati; A Bahal; A K Dhar; N Chakravorty; M P Muttagikar; R Lakhtakia
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Molecular diagnosis in Ewing family tumors: the Rizzoli experience--222 consecutive cases in four years.

Authors:  Gabriella Gamberi; Stefania Cocchi; Stefania Benini; Giovanna Magagnoli; Luca Morandi; Jennifer Kreshak; Marco Gambarotti; Piero Picci; Licciana Zanella; Marco Alberghini
Journal:  J Mol Diagn       Date:  2011-03-31       Impact factor: 5.568

3.  Multiple splice variants of EWSR1-ETS fusion transcripts co-existing in the Ewing sarcoma family of tumors.

Authors:  Barbara Patócs; Krisztina Németh; Miklós Garami; Gabriella Arató; Ilona Kovalszky; Miklós Szendrői; György Fekete
Journal:  Cell Oncol (Dordr)       Date:  2013-03-14       Impact factor: 6.730

4.  Establishment of multiplex RT-PCR to detect fusion genes for the diagnosis of Ewing sarcoma.

Authors:  Hitomi Ueno-Yokohata; Hajime Okita; Keiko Nakasato; Chikako Kiyotani; Motohiro Kato; Kimikazu Matsumoto; Nobutaka Kiyokawa; Atsuko Nakazawa; Takako Yoshioka
Journal:  Diagn Pathol       Date:  2021-11-08       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.